{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Influencia de la depresion en el diagnostico inicial y evolutivo del deterioro cognitivo.",
        "Introduccion. La depresion y el deterioro cognitivo mantienen una estrecha y compleja relacion, que podria verse alterada por el tratamiento antidepresivo. Objetivo. Analizar la influencia de la depresion y del tratamiento antidepresivo en el diagnostico cognitivo inicial y evolutivo de los pacientes remitidos a neurologia por quejas o sospecha de deterioro cognitivo. Pacientes y metodos. Se estudio a todos los pacientes remitidos a una consulta de neurologia por quejas o sospecha de deterioro cognitivo durante un periodo de nueve a\u00f1os. Se analizo la influencia de las variables demograficas y de las variables relacionadas con la depresion en el diagnostico cognitivo y en la situacion cognitivo-funcional inicial y tras un a\u00f1o de seguimiento. Resultados. Se incluyo a 582 pacientes (edad media: 77,6 \u00b1 7 a\u00f1os; mujeres, 64,9%). La frecuencia de depresion actual o en el pasado era, respectivamente, del 25,4% y 17,2%. El 20,6% de los pacientes recibia tratamiento con farmacos antidepresivos y el 31,2% tomaba ansioliticos/hipnoticos. Se dispuso de seguimiento al cabo de un a\u00f1o en 320 pacientes (59,8%). En el analisis ajustado, el tratamiento ansiolitico/hipnotico se asocio a una peor situacion cognitiva y funcional inicial, mientras que la depresion en el pasado y la presencia de distimia en la visita inicial se asociaron a una evolucion favorable (p < 0,05). Conclusiones. La depresion pasada o actual no es un factor de mal pronostico en los pacientes remitidos al neurologo por posible deterioro cognitivo."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28675257",
  "DateCompleted": {
    "Year": "2018",
    "Month": "05",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "05",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "spa"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1576-6578",
      "JournalIssue": {
        "Volume": "65",
        "Issue": "2",
        "PubDate": {
          "Year": "2017",
          "Month": "Jul",
          "Day": "16"
        }
      },
      "Title": "Revista de neurologia",
      "ISOAbbreviation": "Rev Neurol"
    },
    "ArticleTitle": "[Influence of depression on the initial diagnosis and the evolution of cognitive impairment].",
    "Pagination": {
      "StartPage": "63",
      "EndPage": "69",
      "MedlinePgn": "63-69"
    },
    "Abstract": {
      "AbstractText": [
        "Depression and cognitive impairment maintain a close and complex relationship, which could be modified by pharmacological treatment.",
        "To analyze the influence of depression and antidepressive medication on the initial diagnosis and the evolution of cognitive impairment.",
        "All the patients derived to a Neurology clinic due to complaints or suspicion of cognitive impairment, during a period of nine years, were studied. The influence of demographic and depression-related variables on initial cognitive diagnosis, cognitive-functional situation and 1-year evolution were analyzed.",
        "A total of 582 patients were included (mean age: 77.6 \u00b1 7.0; 64.9% women). Frequency of current and past depression were, respectively, 25.4% and 17.2%. In addition, 20.6% of the patients were taking antidepressant medication and 31.2% were on anxiolytic/hypnotic treatment. One-year follow-up visit was available in 320 (59.8%) of patients. In the adjusted analysis, anxiolytic/hypnotic treatment was associated with a worse cognitive-functional situation in the initial visit, while past depression and presence of dystimia were associated with a favorable evolution (p < 0.05).",
        "Past or current depression are not associated with bad prognosis in patients derived to neurologist due to possible cognitive impairment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital General Universitario Gregorio Maranon, Madrid, Espana."
          }
        ],
        "LastName": "Cenalmor-Aparicio",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital General Universitario Gregorio Maranon, Madrid, Espana."
          }
        ],
        "LastName": "Bravo-Quelle",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital General Universitario Gregorio Maranon, Madrid, Espana."
          }
        ],
        "LastName": "Miranda-Acuna",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital General Universitario Gregorio Maranon, Madrid, Espana."
          }
        ],
        "LastName": "Luque-Buzo",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital Nuestra Senora del Prado, 45600 Talavera de la Reina, Espana."
          }
        ],
        "LastName": "Herrera-Tejedor",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hospital General Universitario Gregorio Maranon, Madrid, Espana."
          }
        ],
        "LastName": "Olazaran-Rodriguez",
        "ForeName": "J",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Observational Study"
    ],
    "VernacularTitle": "Influencia de la depresion en el diagnostico inicial y evolutivo del deterioro cognitivo."
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "Rev Neurol",
    "NlmUniqueID": "7706841",
    "ISSNLinking": "0210-0010"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hypnotics and Sedatives"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Cognitive Dysfunction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "etiology",
        "psychology"
      ],
      "DescriptorName": "Dementia"
    },
    {
      "QualifierName": [
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Dysthymic Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Educational Status"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hypnotics and Sedatives"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mental Status and Dementia Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Symptom Assessment"
    }
  ]
}